Agilon Health
Enables primary-care groups to run Medicare-focused risk-bearing care models.
Something off on this page? Send us feedback.
Profile
Helps community primary-care groups move Medicare senior care into value-based arrangements, mainly through Medicare Advantage capitation. The model combines the agilon platform, long-term physician partnerships, and a physician network, with revenue tied to payor contracts and federal healthcare programs.
Partners with community-based primary-care physician groups in the United States, forming local risk-bearing entities that contract with Medicare Advantage payors. The operating model centers on the agilon platform, long-term physician partnerships, and the agilon network.
Provides technology, people, process, and capital so physician partners can identify care gaps, integrate with payors, and manage quality and cost outcomes. Medical services revenue comes mainly from capitation arrangements for attributed Medicare Advantage members.
Also participates in CMS ACO Models through equity-method investments, while most consolidated revenue remains Medicare Advantage-linked. The business depends on payor contracts, CMS payment rates, risk adjustment, member attribution, claims data, and physician partners' execution under value-based care arrangements.
Company facts
Key statistics
Year to date +450% · Average volume (30d) 339.6K
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | Wells Fargo | Reiterate | Overweight | $141 | $146 | |
| Aug 11, 2026 | Citigroup | Upgrade | Sell | Neutral | ||
| Aug 10, 2026 | Citigroup | Upgrade | Sell | Neutral | ||
| Aug 6, 2026 | Robert W. Baird | Target | $6 | $116 | ||
| Aug 6, 2026 | Truist Financial | Target | $6.50 | $112 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026Q2 FY26 | $0.14 | $1.04 | +622.2% | $1.45B | $1.49B | +3.0% | −19.49% |
| May 6, 2026Q1 FY26 | $1.13 | $1.80 | +59.3% | $1.38B | $1.42B | +2.9% | +117.81% |
| Feb 25, 2026Q4 FY25 | −$6.75 | −$11.50 | −70.4% | $1.47B | $1.57B | +6.8% | +18.96% |
| Nov 4, 2025Q3 FY25 | −$0.18 | −$0.27 | −50.0% | $1.42B | $1.44B | +1.0% | +4.03% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $1.53B | $1.39B | $1.44B | $1.57B | $1.42B | $1.49B | |
| Gross profit | $50.7M | −$52.4M | −$67.6M | −$97.6M | $58.2M | $107.1M | |
| Operating income | −$22.1M | −$116.0M | −$131.3M | −$155.8M | $10.1M | $11.8M | |
| Net income | $12.1M | −$104.4M | −$110.2M | −$188.9M | $30.0M | $18.0M | |
| Diluted EPS | $0.75 | −$6.25 | −$6.75 | −$11.50 | $1.80 | $1.04 | |
| Gross margin | 3.3% | -3.8% | -4.7% | -6.2% | 4.1% | 7.2% | |
| Operating margin | -1.4% | -8.3% | -9.1% | -9.9% | 0.7% | 0.8% |
Fiscal years (4-quarter sums)FY21 $1.83B · FY22 $2.71B · FY23 $4.08B · FY24 $6.06B · FY25 $5.93B
Revenue by product · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $185.6M · Total debt $33.4M · Total assets $1.59B · Shareholders' equity $227.5M
Dividends
No dividends on record.
Ownership
Institutions and insiders are filed separately and overlap, so together they can pass the whole company. No split is drawn from them.
Shares outstanding 16.68M · Float 11.71M · 70.2% free float
A split settled inside the quarter being compared, so quarter-on-quarter change is not shown.
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Clayton, Dubilier & Rice, LLC | 4.00M | 23.98% | 13F | Jul 29, 2026 |
| Morgan Stanley | 2.01M | 12.05% | 13F | Aug 13, 2026 |
| North Peak Capital Management, LLC | 1.49M | 8.90% | 13F | Aug 14, 2026 |
| BlackRock, Inc. | 1.15M | 6.87% | 13F | Aug 7, 2026 |
| AQR Capital Management LLC | 692.5K | 4.15% | 13F | Aug 14, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Mar 2, 2026 | Benjamin Shaker | officer: Chief Markets Officer | +500,000 | $0.6021 |
| Nov 12, 2025 | John William Wulf | director | +81,000 | $0.6289 |
Peers
- UnitedHealth Group
Scale alternative in MA, Optum value-based care, and provider enablement
- CVS Health
Aetna and Oak Street combine MA coverage with senior primary care
- Humana
Medicare Advantage and CenterWell senior primary care alternative
- Astrana Health
Risk-bearing physician platform across Medicare and multi-payer care
- Privia Health
Physician enablement and ACO platform for value-based contracts
- Alignment Healthcare
Medicare Advantage plan operator with tech-enabled senior care
- P3 Health Partners
Physician-led MA risk platform serving capitated members
- Evolent
Specialty-care value platform and former primary-care ACO owner
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Agilon Health | $92.54 | −0.02% | $1.54B | — | — | 0.3 | +7.2% |
| UnitedHealth Group | $392.50 | −0.12% | $356.86B | 25.3 | 18.4 | 0.8 | +0.4% |
| CVS Health | $93.07 | +0.02% | $118.74B | 24.6 | 11.5 | 0.3 | +7.3% |
| Humana | $386.23 | +0.16% | $46.30B | 36.5 | 31.2 | 0.3 | +26.2% |
| Astrana Health | $37.96 | 0.00% | $1.88B | 46.4 | 23.6 | 0.5 | +48.5% |
| Privia Health | $20.79 | +0.10% | $2.62B | 95.9 | 54.4 | 1.1 | +21.4% |
| Alignment Healthcare | $13.62 | −0.04% | $2.83B | 73.0 | 46.0 | 0.6 | +31.6% |
| P3 Health Partners | $9.22 | −0.43% | $30.2M | — | — | 0.0 | +8.6% |
| Evolent | $4.58 | −0.22% | $517.4M | — | 13.6 | 0.2 | +46.9% |
| Median | 41.5 | 23.6 | 0.4 | +23.8% |